How pre-launch scientific activities are associated with launch success
Experts from Pfizer and Veeva explore a recent Veeva Pulse Report showing that targeted scientific outreach is associated with 40% faster treatment adoption.
Experts from Pfizer and Veeva explore a recent Veeva Pulse Report showing that targeted scientific outreach is associated with 40% faster treatment adoption.
This webinar examines, based on the prevailing pre-launch situation, the strategic focus areas for Medical Affairs teams to consider during launch preparation and discuss approaches to achieve excellence across key activities.
This webinar discusses the leadership role that Medical Affairs plays in the development and execution of a cross-functional launch plan. An upcoming gene therapy launch will provide real-life examples of how Medical Affairs can be an effective strategic leader through launch planning.
In this module you will: review the changing role of Medical Affairs and how it has become a strong strategic partner in product launch excellence (LE); gain insights into the components of LE; identify processes, systems, and tools to support LE; utilize templates to support LE planning.
After completing this Webinar, participants will be better able to recognize and avoid pre-launch pitfalls from the perspective of cross-functional partners from Commercial, Market Access, and R&D.
Standards & Guidance plus downloadable templates for Medical Affairs Launch Excellence
This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.